Related Experiment Video
Updated: Aug 23, 2025

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes
Published on: April 10, 2015
Ruthenium polypyridine complexes with triphenylamine groups as antibacterial agents against Staphylococcus aureus
Li Jiang1, Yuanyuan Ma1, Yanshi Xiong1
1Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China.
Abstract:
Due to the emergence and wide spread of methicillin-resistant Staphylococcus aureus, the treatment of this kind of infection becomes more and more difficult. To solve the problem of drug resistance, it is urgent to develop new antibiotics to avoid the most serious situation of no drug available. Three new Ru complexes [Ru (dmob)2PMA] (PF6)2 (Ru-1) [Ru (bpy)2PMA] (PF6)2 (Ru-2) and [Ru (dmb)2PMA] (PF6)2 (Ru-3) (dmob = 4,4'-dimethoxy-2,2'-bipyridine, bpy = 2,2'-bipyridine, dmb = 4,4'-dimethyl-2,2'-bipyridine and PMA = N-(4-(1H-imidazo [4,5-f] [1,10] phenanthrolin-2-yl) -4-methyl-N-(p-tolyl) aniline) were synthesized and characterized by 1H NMR, 13C NMR and HRMS. The detailed molecular structure of Ru-3 was determined by single crystal X-ray diffraction. Their antibacterial activities against Staphylococcus aureus (Staphylococcus aureus) were obvious and Ru-3 showed the best antibacterial effect with the minimum inhibitory concentration value of 4 μg ml-1. Therefore, further study on its biological activity showed that Ru-3 can effectively inhibit the formation of biofilm and destroy cell membrane. In vitro hemolysis test showed that Ru-3 has almost negligible cytotoxicity to mammalian red blood cells. In the toxicity test of wax moth insect model, Ru-3 exhibited low toxicity in vivo. These results, combined with histopathological studies, strongly suggest that Ru-3 was almost non-toxic. In addition, the synergistic effect of Ru-3 with common antibiotics such as ampicillin, chloramphenicol, tetracycline, kanamycin and gentamicin on Staphylococcus aureus was detected by chessboard method. Finally, in vivo results revealed that Ru-3 could obviously promote the wound healing of Staphylococcus aureus infected mice.
Insights
New ruthenium complexes show potent antibacterial activity against methicillin-resistant Staphylococcus aureus. Ru-3 effectively inhibits biofilm formation and promotes wound healing with low toxicity, offering a promising alternative to conventional antibiotics.
Area of Science:
- Coordination Chemistry
- Antimicrobial Agents
- Materials Science
Background:
- Rising prevalence of antibiotic-resistant bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA), necessitates novel therapeutic strategies.
- Existing antibiotics are becoming less effective, creating an urgent need for new antimicrobial compounds to combat difficult-to-treat infections.
Purpose of the Study:
- To synthesize and characterize novel ruthenium complexes as potential antibacterial agents against Staphylococcus aureus.
- To evaluate the efficacy of these complexes in inhibiting bacterial growth, biofilm formation, and promoting wound healing.
Main Methods:
- Synthesis and characterization of three new ruthenium complexes (Ru-1, Ru-2, Ru-3) using NMR and HRMS.
- Determination of the molecular structure of Ru-3 via single crystal X-ray diffraction.
- Assessment of antibacterial activity, minimum inhibitory concentration (MIC), biofilm inhibition, cell membrane destruction, cytotoxicity (hemolysis), and in vivo toxicity in a wax moth model.
Main Results:
- All synthesized ruthenium complexes exhibited antibacterial activity against Staphylococcus aureus.
- Complex Ru-3 demonstrated the most potent activity with an MIC of 4 μg/mL, effectively inhibiting biofilm formation and destroying bacterial cell membranes.
- Ru-3 showed negligible cytotoxicity to mammalian red blood cells and low toxicity in vivo, with synergistic effects observed when combined with conventional antibiotics.
Conclusions:
- Ruthenium complex Ru-3 is a highly effective antibacterial agent against Staphylococcus aureus, with significant potential for treating resistant infections.
- Ru-3's ability to inhibit biofilm formation, disrupt cell membranes, and promote wound healing, coupled with its low toxicity, makes it a promising candidate for further development.
- The synergistic effects with existing antibiotics suggest a multifaceted therapeutic approach for combating Staphylococcus aureus infections.
More Related Videos
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
12:27Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
Published on: January 3, 2020
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Diazonium Group Substitution: –OH and –H
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Preparation and Reactions of Sulfides
Combined Effects of Drugs: Synergism
Such synergistic combinations...